GENEVA, Dec. 29 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/056126) for "USE OF ANTI-CXCR5 ANTIBODIES" on Jun 16, 2025. With publication no. WO/2025/262564, the details related to the patent application was published on Dec 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): GUZOVA, Julia Alexandrovna (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), OEMAR, Barry Setiawan (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139)
Abstract: The invention provides method of using antibodies, and antigen-bindin...